Navigation Links
Jury Renders Verdict for Ormco - Align's Invisalign(R) Product Infringes Ormco Patent
Date:6/26/2009

ORANGE, Calif., June 26 /PRNewswire/ -- Ormco Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today that it received a favorable jury verdict in its patent infringement case against Align Technology, Inc., the maker of Invisalign(R), a clear, removable appliance used to straighten teeth. The jury unanimously found that Align's process for creating its Invisalign(R) aligners infringed several claims of a patent held by Ormco. The claims at issue cover a process for creating 3D representations of the teeth of a patient for use in modeling tooth movement, a technique used in orthodontic treatment.

In addition to finding Align infringed the patent claims asserted by Ormco, the jury rejected Align's assertions that the claims at issue in the lawsuit were invalid and unenforceable. "We are pleased that the jury reached a verdict in favor of Ormco," said Don Tuttle, President of Ormco Corporation. He then added that, "We have long maintained that Align's process for creating aligners used our intellectual property and that the attacks on the enforceability of our patent claims were unfounded."

The Court has not yet entered judgment in the case. Although Ormco expects that Align will file post-trial motions with the Court trying to alter the jury's decision, Ormco believes a judgment on the verdict will be entered. Following the entry of the judgment on the verdict, Ormco will be entitled to request the court issue a permanent injunction to enjoin Align's continued infringement and to seek a reasonable royalty on all of their US sales made since January of 2003 by Align of its Invisalign(R) aligners.

    Please contact:
    Matt R. McGrew
    Vice President, Investor Relations
    Danaher Corporation
    Telephone: (202) 828-0850


'/>"/>
SOURCE Ormco Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SOX9 renders melanomas sensitive to retinoic acid and stops tumor growth
2. Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation
3. No Verdict Yet on Grape Seed Extract vs. Breast Cancer
4. AAID Hails Florida Court Verdict Allowing Advertising of Bona Fide Dental Credentials
5. Chicago Lawyers Represents Plaintiff in Trial That Results in $23.7 Million Jury Verdict over Fatal 2004 Trucking Accident
6. $12 Million New Jersey Medical Malpractice Verdict for Wrongful Death of a 21-Year-Old Man After Having Wisdom Teeth Removed
7. Subway Accident Victim Wins $3.595 Million Verdict Against The New York City Transit Authority
8. Steve Teal, Santa Rosa Attorney, Obtains $850,000 for Client in Highest Hospital Negligence Verdict in Mendocino County
9. New York Attorney Obtains $2.25 Million Verdict for Client Injured on Grounds of Bronx Eye Surgery Clinic
10. Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit
11. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: